SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-249221
Filing Date
2017-08-07
Accepted
2017-08-07 07:01:52
Documents
58
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d403501d10q.htm 10-Q 603194
2 EX-31.1 d403501dex311.htm EX-31.1 6513
3 EX-31.2 d403501dex312.htm EX-31.2 6653
4 EX-32.1 d403501dex321.htm EX-32.1 3880
11 GRAPHIC g403501g0804034526332.jpg GRAPHIC 43116
12 GRAPHIC g403501g0804034526551.jpg GRAPHIC 34649
  Complete submission text file 0001193125-17-249221.txt   3014919

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT epzm-20170630.xml EX-101.INS 462048
6 XBRL TAXONOMY EXTENSION SCHEMA epzm-20170630.xsd EX-101.SCH 35624
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20170630_cal.xml EX-101.CAL 51425
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20170630_def.xml EX-101.DEF 97183
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20170630_lab.xml EX-101.LAB 300841
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20170630_pre.xml EX-101.PRE 203139
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 171009957
SIC: 2834 Pharmaceutical Preparations